Details
Title
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Author
Bader, Jakob M 1
; Geyer, Philipp E 2
; Müller, Johannes B 1
; Strauss, Maximilian T 1
; Koch, Manja 3
; Leypoldt, Frank 4 ; Koertvelyessy, Peter 5 ; Bittner, Daniel 6 ; Schipke, Carola G 7 ; Incesoy, Enise I 8 ; Peters, Oliver 9 ; Deigendesch, Nikolaus 10 ; Simons, Mikael 11 ; Jensen, Majken K 12 ; Zetterberg, Henrik 13 ; Mann, Matthias 2
1 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
2 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany; NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
3 Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
4 Institute of Clinical Chemistry, Faculty of Medicine, Kiel University, Kiel, Germany; Department of Neurology, Faculty of Medicine, Kiel University, Kiel, Germany
5 Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
6 Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany
7 Experimental & Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, & Berlin Institute of Health, Berlin, Germany
8 Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany
9 Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases, Berlin, Germany
10 Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
11 German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany
12 Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Public Health, University of Copenhagen, Copenhagen, Denmark
13 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; UK Dementia Research Institute at UCL, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
; Geyer, Philipp E 2
; Müller, Johannes B 1
; Strauss, Maximilian T 1
; Koch, Manja 3
; Leypoldt, Frank 4 ; Koertvelyessy, Peter 5 ; Bittner, Daniel 6 ; Schipke, Carola G 7 ; Incesoy, Enise I 8 ; Peters, Oliver 9 ; Deigendesch, Nikolaus 10 ; Simons, Mikael 11 ; Jensen, Majken K 12 ; Zetterberg, Henrik 13 ; Mann, Matthias 2
1 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
2 Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany; NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
3 Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
4 Institute of Clinical Chemistry, Faculty of Medicine, Kiel University, Kiel, Germany; Department of Neurology, Faculty of Medicine, Kiel University, Kiel, Germany
5 Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
6 Department of Neurology, Medical Faculty, Otto von Guericke University Magdeburg, Magdeburg, Germany
7 Experimental & Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, & Berlin Institute of Health, Berlin, Germany
8 Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany
9 Department of Psychiatry, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin & Berlin Institute of Health, Charité Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases, Berlin, Germany
10 Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
11 German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany
12 Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Public Health, University of Copenhagen, Copenhagen, Denmark
13 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; UK Dementia Research Institute at UCL, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
Section
Articles
Publication year
2020
Publication date
Jun 2020
e-ISSN
17444292
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2447198007
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.